share_log

Quince Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Sofinnova Capital VIII (“SC VIII”)(5.1%),Sofinnova Partners SAS, a French corporation (“SP SAS”)(5.1%), etc.

Quince Therapeutics | SC 13G:超过5%持股股东披露文件-Sofinnova Capital VIII (“SC VIII”)(5.1%),Sofinnova Partners SAS, a French corporation (“SP SAS”)(5.1%)等

SEC announcement ·  02/12 09:04
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息